These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 29269358)

  • 1.
    Baumrin E; Piette EW; Micheletti RG
    BMJ Case Rep; 2017 Dec; 2017():. PubMed ID: 29269358
    [No Abstract]   [Full Text] [Related]  

  • 2. Stenotrophomonas maltophilia: an emerging global opportunistic pathogen.
    Brooke JS
    Clin Microbiol Rev; 2012 Jan; 25(1):2-41. PubMed ID: 22232370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stenotrophomonas maltophilia keratitis treated with trimethoprim-sulfamethoxazole.
    Díez-Álvarez L; Lumbreras-Fernández B; García-Pérez JL
    Arch Soc Esp Oftalmol; 2015 Nov; 90(11):539-41. PubMed ID: 26008926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stenotrophomonas maltophilia: An Emerging Pathogen of the Respiratory Tract.
    Kanderi T; Shrimanker I; Mansoora Q; Shah K; Yumen A; Komanduri S
    Am J Case Rep; 2020 May; 21():e921466. PubMed ID: 32448864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial susceptibility pattern of Burkholderia cepacia complex & Stenotrophomonas maltophilia over six years (2007-2012).
    Gautam V; Kumar S; Kaur P; Deepak T; Singhal L; Tewari R; Ray P
    Indian J Med Res; 2015 Oct; 142(4):492-4. PubMed ID: 26609043
    [No Abstract]   [Full Text] [Related]  

  • 6. Stenotrophomonas maltophilia: emerging disease patterns and challenges for treatment.
    Abbott IJ; Slavin MA; Turnidge JD; Thursky KA; Worth LJ
    Expert Rev Anti Infect Ther; 2011 Apr; 9(4):471-88. PubMed ID: 21504403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of pulmonary haemorrhage and acute respiratory distress syndrome caused by fulminant Stenotrophomonas maltophilia respiratory infection in a patient with acute lymphoblastic leukaemia - case report.
    Andrei S; Ghiaur A; Brezeanu L; Martac C; Nicolau A; Coriu D; Droc G
    BMC Infect Dis; 2020 Sep; 20(1):658. PubMed ID: 32912165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Stenotrophomonas maltophilia and tigecycline in clinical practice].
    Conde-Estévez D; Grau S; Alvarez-Lerma F
    Enferm Infecc Microbiol Clin; 2012 Mar; 30(3):170-1. PubMed ID: 22277371
    [No Abstract]   [Full Text] [Related]  

  • 9. Stenotrophomonas maltophilia: An emerging opportunistic nosocomial pathogen in a tertiary care hospital in Al Batinah North Governorate, Oman.
    Sannathimmappa MB; Nambiar V; Aravindakshan R; Al-Kasaby NM
    Sultan Qaboos Univ Med J; 2021 Feb; 21(1):e66-e71. PubMed ID: 33777425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New strategies against Stenotrophomonas maltophilia: a serious worldwide intrinsically drug-resistant opportunistic pathogen.
    Brooke JS
    Expert Rev Anti Infect Ther; 2014 Jan; 12(1):1-4. PubMed ID: 24308713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stenotrophomonas maltophila cellulitis in an immunocompromised patient presenting with purpura, diagnosed on skin biopsy.
    Gao Y; Minca EC; Procop GW; Bergfeld WF
    J Cutan Pathol; 2016 Nov; 43(11):1017-1020. PubMed ID: 27406009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review on
    Majumdar R; Karthikeyan H; Senthilnathan V; Sugumar S
    Recent Pat Biotechnol; 2022; 16(4):329-354. PubMed ID: 35549857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Stenotrophomonas maltophilia in hospital-acquired infection.
    Looney WJ
    Br J Biomed Sci; 2005; 62(3):145-54; quiz 1 p following 154. PubMed ID: 16196464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors and molecular mechanisms associated with trimethoprim-sulfamethoxazole resistance in Stenotrophomonas maltophilia in Mexico.
    Herrera-Heredia SA; Pezina-Cantú C; Garza-González E; Bocanegra-Ibarias P; Mendoza-Olazarán S; Morfín-Otero R; Camacho-Ortiz A; Villarreal-Treviño L; Rodríguez-Noriega E; Paláu-Davila L; Maldonado-Garza HJ; Flores-Treviño S
    J Med Microbiol; 2017 Aug; 66(8):1102-1109. PubMed ID: 28771141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successfully treated nosocomial Stenotrophomonas maltophilia bacteremia following desensitization to trimethoprim-sulfamethoxazole.
    Yilmaz M; Celik AF; Mert A
    J Infect Chemother; 2007 Apr; 13(2):122-3. PubMed ID: 17458682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Toxin-Antitoxin Systems of the Opportunistic Pathogen
    Klimkaitė L; Armalytė J; Skerniškytė J; Sužiedėlienė E
    Toxins (Basel); 2020 Oct; 12(10):. PubMed ID: 33019620
    [No Abstract]   [Full Text] [Related]  

  • 17. Biclonal bacteremia due to Stenotrophomonas maltophilia in a cancer patient.
    Lechner A; Hindler JF; Nelson SF
    Eur J Clin Microbiol Infect Dis; 2001 Sep; 20(9):673-5. PubMed ID: 11714054
    [No Abstract]   [Full Text] [Related]  

  • 18. First report of survival in two patients with hematologic malignancy and Stenotrophomonas maltophilia hemorrhagic pneumonia treated with trimethoprim-sulfamethoxazole-based combination antibiotic therapy.
    Penagos SC; Giraldo N; Vallejo C; McEwen O; Hidron A
    J Infect Chemother; 2020 Apr; 26(4):397-399. PubMed ID: 31882384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal Transplant Recipient with Concurrent COVID-19 and Stenotrophomonas maltophilia Pneumonia Treated with Trimethoprim/Sulfamethoxazole Leading to Acute Kidney Injury: A Therapeutic Dilemma.
    Mohamed MA; Kaur J; Wani F; Kichloo A; Bhanot R
    Am J Case Rep; 2020 Aug; 21():e926464. PubMed ID: 32799217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and Microbiologic Outcomes in Patients with Monomicrobial Stenotrophomonas maltophilia Infections.
    Nys C; Cherabuddi K; Venugopalan V; Klinker KP
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31427300
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.